SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2021$71,000
+20.3%
21,394
-3.2%
0.00%0.0%
Q2 2021$59,000
-34.4%
22,094
-47.2%
0.00%
-50.0%
Q1 2021$90,000
+30.4%
41,877
+49.7%
0.00%
+100.0%
Q4 2020$69,00027,9770.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q3 2021
NameSharesValueWeighting ↓
GARDNER LEWIS ASSET MANAGEMENT L P 1,249,778$2,750,0000.55%
Beryl Capital Management LLC 1,131,772$2,490,0000.26%
DELTEC ASSET MANAGEMENT LLC 155,614$342,0000.08%
Knott David M Jr 41,700$92,0000.04%
TPG GP A, LLC 1,020,748$2,246,0000.04%
GABELLI & Co INVESTMENT ADVISERS, INC. 40,900$90,0000.01%
Ergoteles LLC 135,323$298,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,600$292,0000.01%
Virtu Financial LLC 20,027$44,0000.00%
GABELLI FUNDS LLC 59,100$130,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders